19.5% margins on spread gains, volumes hit by Hormuz disruption

Supreme Petrochem Limited — Q1 FY27 Earnings Call (held July 29, 2026; results for quarter ended June 30, 2026)

1. Overall Tone of Management: Neutral (leaning Optimistic on profitability, cautious on volumes/outlook)

• Management highlighted strong profitability: “operating EBITDA… reflecting a strong growth of 188%… margins improving to 19.53%.”
• However, they repeatedly emphasized abnormal, fluid conditions and no guidance: “Giving any guidance at this stage… is very difficult,” and margins are “like an aberration… will get normalized.”

2. Key Themes from Management Commentary

• Profitability driven by global spreads/deltas, not volumes
• Volumes fell sharply (“decline of 24.5%… primarily… negligible exports… subdued demand from the non-OEM segment”).
• Yet EBITDA surged due to “Wider delta… between Styrene Monomer and downstream products.”
• West Asia geopolitical disruption as the dominant operational constraint
• “interruption in liquid and container shipments… Strait of Hormuz”
• “all three styrene plants… suspended… due to safety reasons”
• Alternate sourcing protected domestic supply, but exports were minimal.
• Import duty changes created unintended market share erosion
• “temporary suspension of import duties… led to unnecessarily increased imports resulting in erosion of market share for domestic producers.”
• Expansion continues, funded internally
• Phase 2 EPS completed; new wide-width EPS board line (150,000 m³) and compounding expansion (50,000 → 80,000 tons) commissioned by June 2027.
• Board approved new 80,000 tons p.a. polystyrene line at Amdoshi; completion expected Dec 2028.
• Total estimated investment: INR 450 crores, “funded entirely through internal accruals.”
• Demand narrative: OEM stable; non-OEM weak but “coming back”
• OEM demand “good… stable.”
• Non-OEM demand “very subdued… almost 50% demand… evaporated,” but later: “non-OEMs are coming back… stabilizing also now.”

3. Q&A Analysis

Theme A: Demand elasticity, import impact, and market share dynamics (non-OEM weakness)

• Core questions
• Why customers accept higher prices; how domestic import situation evolved.
• Whether non-OEM demand fell due to high prices vs imports taking share.
• Management response
• Non-OEM demand down “partly because of the high prices.”
• Imports were linked to duty exemption: “imports were coming because there was a duty exemption… close to 20,000 tons.”
• They downplayed import-driven share loss as the primary cause: “demand was generally down… non-OEMs… down almost close to 50%.”
• Notable/partial aspects
• They cite “authentic import data is not available” due to a government notification, relying on “market sources” (e.g., “around 20,000 tons”).
• Exports were quantified as extremely weak: “barely around 10.12% of what we normally export.”

Theme B: Recovery path after disruptions (how different vs past cycles)

• Core questions
• How this disruption differs from prior cycles and what recovery looks like.
• Strategy to improve volumes in upcoming quarters.
• Management response
• Strong differentiation: “not like what has happened in the past… prolonged… full region… not one plant.”
• Strategy: export-led growth and capacity readiness—“country is moving towards exports… demand growth is what is leading us to build additional capacity.”
• Evasive/strong
• They avoided timing/volume guidance due to “very fluid” conditions.

Theme C: ABS/XPS/compounding ramp-up and market acceptance

• Core questions
• Compounding volumes outlook for FY27; ABS demand and ramp-up.
• Whether expanded capacity can be fully utilized.
• Management response
• Compounding: “compounds are doing well… moving more towards the ABS compounds… setting up lines mainly for the ABS compounds.”
• Utilization confidence: “Certainly yes, that is the aim… in the next 2 years… use this capacity.”
• ABS volumes: they refused to break out ABS volumes (“We don’t give any volume separately”).
• Notable
• They explicitly stated ABS market growth and India demand drivers (energy-efficient buildings/cold storages/construction).

Theme D: Margin sustainability vs “aberration”

• Core questions
• Sustainability of ~19% margin; what happens if non-OEM demand returns.
• Impact of higher freight/alternate sourcing on future margins.
• Management response
• Margin is spread-driven and expected to normalize: “This margin… is like an aberration… will get normalized over a period of time.”
• They refused quantitative margin guidance: “very difficult… margins are dependent upon global deltas.”
• Freight/sourcing: “freight cost will increase… longer voyage time… freight rates will go up.”
• Evasive
• No ballpark margin for FY27–FY28; only qualitative normalization logic.

Theme E: CAPEX roadmap and funding

• Core questions
• Whether the INR 450 cr includes XPS; CAPEX allocation; FY27 CAPEX number.
• Asset turn expectations.
• Management response
• INR 450 cr includes XPS line: “that cost is included in the 900 crores” (in another answer they also said total CAPEX ~900 cr for “this all CAPEX put together”).
• FY27 CAPEX: “closer to 900 crores.”
• Asset turnover: “All the products put together… on full capacity basis, there will be twice.”
• Potential inconsistency
• Two different totals appear in the call: INR 450 crores (expansion projects mentioned in opening) vs INR ~900 crores (CAPEX “put together” for FY27). Management did not clearly reconcile scope/timing.

4. Guidance / Outlook

Explicit guidance (quantitative)

• Commissioning timelines
• Wide-width EPS board line + compounding expansion: commissioned by June 2027
• Polystyrene 5th line (Amdoshi): expected by Dec 2028
• “All capacities will be on board by March 2029.”
• CAPEX
• Expansion projects: INR 450 crores (funded via internal accruals)
• FY27 CAPEX: ~INR 900 crores (management stated “this all CAPEX put together would be closer to 900 crores”)
• Utilization / capacity use
• Compounding capacity utilization intent: “in the next 2 years… use this capacity.”
• Export strategy: capacity needed for “3 to 6 months period of high demand.”

Implicit signals (qualitative)

• Volumes
• No volume guidance due to “fluid” West Asia/shipping/styrene availability.
• Non-OEM demand is “coming back” and “stabilizing,” but exports remain constrained.
• Margins
• Current high margins are spread-driven and expected to normalize as deltas revert.
• Demand drivers
• Growth expected from exports and from India’s construction/cold storage/energy-efficient building segments.
• Risk posture
• Management repeatedly avoided forecasting until “situation becomes very normal.”

5. Standout Statements (direct / highly revealing)

• Profitability vs volume decoupling
• “The revenue growth despite lower volume sales… increase in the raw material prices due to conflict in West Asia.”
• “We did not have any volume growth rather there was negative volumes… margins… because the global deltas… widened.”
• Export collapse quantified
• “exports were minimal… exported barely around 10.12% of what we normally export.”
• Non-OEM demand shock
• “Almost 50% demand from the non-OEM segment had evaporated in this quarter.”
• Normalization expectation
• “This margin… is like an aberration… will get normalized over a period of time.”
• No guidance due to uncertainty
• “Giving any guidance at this stage when the situation is very fluid is very difficult.”
• Capacity utilization confidence
• “Certainly yes… in the next 2 years… we should be able to use this capacity.”

6. Red Flags / Positive Signals

Red flags
– No quantitative outlook on volumes/margins despite analysts asking—management repeatedly cited “fluid” conditions.
– Data opacity on imports: “authentic import data is not available… publication… a crime,” relying on “market sources.”
– CAPEX scope ambiguity: INR 450 cr vs INR 900 cr mentioned without clear reconciliation.
– Margin sustainability not addressed with numbers; only “aberration/normalization” language.

Positive signals
– Domestic supply continuity despite supply chain disruption: “able to meet the entire requirement of its domestic customers without any interruption.”
– Expansion funded internally: “funded entirely through internal accruals.”
– Non-OEM demand recovery signal: “non-OEMs are coming back… stabilizing also now.”
– Strategic shift toward higher-margin compounds/ABS: “moving more towards the ABS compounds… setting up lines mainly for the ABS compounds.”

7. Historical Comparison & Consistency Analysis (vs prior 3–4 calls)

a. Change in Tone Over Time

• Q2/H1 FY26 (Oct 2025): cautious, explaining demand weakness from monsoons, destocking, and equipment issues; still provided some directional expectations.
• Q3 FY26 (Jan 2026): more constructive—styrene stabilized; ABS commissioning progress; but still uncertainty due to equipment malfunction.
• Q4 FY26 (Apr 2026): relatively confident on quarter performance; acknowledged West Asia disruption in March and inventory uncertainty; still gave some expectations like “if normalcy returns by June end… 8% to 10% volume growth.”
• Q1 FY27 (Jul 2026): more cautious on forward-looking numbers: “Giving any guidance… difficult,” and margins described as “aberration.”
• Classification shift: More Cautious (less willingness to quantify guidance; more emphasis on abnormality and normalization).

b. Tracking Past Commitments vs Outcomes

• Past statement (Q4 FY26, Apr 2026): “If normalcy returns by June end… we expect… 8% to 10% volume growth this year.”
• What happened by Q1 FY27: volumes fell -24.5% YoY (70,842 MT vs 93,853 MT).
• Flag: ❌ Missed / Delayed (normalcy did not return by June; disruption persisted).
• Past statement (Q4 FY26): EPS Phase-II commissioned on April 14, 2026 (this was a commitment/outcome).
• Current call: “successfully completed the phase 2 expansion of our EPS capacity.”
• Flag: ✅ Delivered.
• Past statement (Q3 FY26, Jan 2026): ABS plant commissioned Sept 2025; equipment failure in Dec; restart timing uncertain.
• Current call: ABS line is now part of broader styrenics/compounding ramp; however, Q1 FY27 does not provide ABS volume breakout and focuses on West Asia disruptions.
• Flag: ⏳ Partially tracked (no clear restart timeline given in Q1 FY27; focus shifted to other constraints).

c. Narrative Shifts

• From “pricing stabilization” to “region-wide logistics failure.”
• Earlier calls discussed monsoons, destocking, and equipment issues.
• Now the dominant narrative is West Asia shipping disruption + regional styrene plant suspensions.
• Exports became the key swing factor.
• Earlier: exports discussed as a growth lever (Europe erratic, shipping time).
• Now: exports are effectively shut down (“barely 10.12%”).
• ABS/compounding emphasis increased, but without volume transparency.
• Management increasingly frames growth as compounds/ABS-driven, while refusing ABS volume disclosure.

d. Consistency & Credibility Signals

• Credibility: Medium
• Consistent explanation that global deltas drive margins and demand is sensitive to high prices.
• Credibility reduced by:
  • Missed volume growth expectation tied to “normalcy by June.”
  • CAPEX number inconsistency (450 cr vs 900 cr) without reconciliation.
  • Import data opacity and reliance on “market estimates.”

e. Evolution of Key Themes

• Demand: OEM stable; non-OEM cyclicality worsened in Q1 FY27 due to price resistance and gas supply issues (new detail vs earlier calls).
• Margins: consistently attributed to global deltas; now explicitly called “aberration” and expected to normalize.
• Expansion: steady long-term capex narrative; timelines pushed into 2027–2029.
• Geopolitics/logistics: becomes the central recurring driver from Q4 FY26 onward and dominates Q1 FY27.

f. Additional Insights (cross-period intelligence)

• A risk is quietly compounding: management previously expected normalization by June (Q4 FY26). By Q1 FY27, they still refuse guidance and quantify export collapse—suggesting the disruption is structural/longer-duration than initially implied.
• The company’s profitability resilience appears increasingly spread-dependent, meaning earnings quality may be less repeatable if deltas compress and exports remain constrained.